Ningxia Zhongke Biotechnology Co., Ltd Share Price

Equities

600165

CNE000000W47

Commodity Chemicals

End-of-day quote Shanghai S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
1.63 CNY -5.23% Intraday chart for Ningxia Zhongke Biotechnology Co., Ltd -15.10% -51.78%

Financials

Sales 2021 192M 26.55M 2.13B Sales 2022 681M 94M 7.53B Capitalization 4.63B 639M 51.17B
Net income 2021 -23M -3.17M -254M Net income 2022 -141M -19.46M -1.56B EV / Sales 2021 55.1 x
Net Debt 2021 1.4B 193M 15.46B Net Debt 2022 1.38B 190M 15.24B EV / Sales 2022 8.82 x
P/E ratio 2021
-395 x
P/E ratio 2022
-32.7 x
Employees 908
Yield 2021 *
-
Yield 2022
-
Free-Float 61.58%
More Fundamentals * Assessed data
Dynamic Chart
Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chinese Securities Regulator Warns Zhongke Biotechnology Over Late Disclosure of Unit's Suspension MT
China stocks roughly flat as sentiment remains subdued; HK shares up RE
China stocks jump on strong PMI data RE
Court Orders Freezing of Zhongke Biotechnology's Bank Accounts Worth 2.6 Million Yuan MT
Benchmark Mortgage Rate Cuts Boost Chinese Stocks; Zhongke Biotechnology Jumps 5% MT
Zhongke Biotechnology's Chairman Resigns MT
Ningxia Zhongke Biotechnology Co., Ltd(XSSC:600165) dropped from S&P Global BMI Index CI
Zhongke Biotechnology Terminates Partnership With New Materials Firm MT
Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Ningxia Zhongke Biotechnology Co., Ltd(XSSC:600165) added to S&P Global BMI Index CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shouguang Jintou New Material Technology Co., Ltd. cancelled the acquisition of an unknown stake in Ningxia Zhongke Biotechnology Co., Ltd. from Shanghai Zhongneng Enterprise Development Co., Ltd. CI
More news
1 day-5.23%
1 week-15.10%
Current month-58.84%
1 month-55.22%
3 months-45.85%
6 months-53.16%
Current year-51.78%
More quotes
1 week
1.56
Extreme 1.56
1.82
1 month
1.56
Extreme 1.56
4.84
Current year
1.42
Extreme 1.42
4.84
1 year
1.42
Extreme 1.42
4.99
3 years
1.42
Extreme 1.42
13.88
5 years
1.42
Extreme 1.42
13.88
10 years
1.42
Extreme 1.42
30.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 01/08/16
Director of Finance/CFO 37 26/07/21
Investor Relations Contact 32 30/10/20
Members of the board TitleAgeSince
Chairman 59 25/07/07
Director/Board Member 58 29/01/23
Chief Executive Officer 51 01/08/16
More insiders
Date Price Change Volume
26/04/24 1.63 -5.23% 164,585,200
25/04/24 1.72 +4.88% 148,389,600
24/04/24 1.64 -5.20% 1,988,100
23/04/24 1.73 -4.95% 2,159,400
22/04/24 1.82 -5.21% 261,200

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
Ningxia Zhongke Biotechnology Co Ltd, formerly NINGXIA XINRI HENGLI STEEL WIRE CO. LTD., is a China-based company mainly engaged in the production and sales of coal-based activated carbon. The Company's main businesses include chemical raw materials and chemical products manufacturing. The Company's products mainly include water purification activated carbon, air purification carbon, solvent recovery carbon, catalyst carrier carbon, chemical protective carbon and mercury removal carbon. The Company is also engaged in the large-scale production of lauric acid. The Company mainly operates its businesses in the domestic market and overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600165 Stock